1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Bharat Biotech announces the price of “ROTAVAC” a potential vaccine against Rotavirus Diarrhoea

ROTAVAC® expecting India licensure during 2014 will be sold to global public markets at a price of US $ 1.0

 
PRLog - Jun. 6, 2011 - Hyderabad, India, 6th June 2011: Bharat Biotech today announced the price of ROTAVAC® India’s first indigenously developed Rotavirus Vaccine.  The vaccine will be sold to global public markets, Governments worldwide including UN procurement agencies at a price of US $ 1.0. Bharat Biotech hopes its new vaccine will help prevent part of the ~ 500,000 child deaths each year caused due to rotavirus diarrhea and improve access to better, affordable rotavirus vaccines.

ROTAVAC® expects India licensure during 2014 and WHO Prequalification in 2015 for supply to UN agencies. The Vaccine is currently undergoing Phase III clinical development for safety and efficacy in 8000 subjects, one of the largest such clinical trial ever conducted in India.  According to CDC estimates, rotavirus causes approximately 352,000–592,000 deaths each year (median, 440,000 deaths) in children

# # #

Bharat Biotech International Limited, Hyderabad, India, is a multidimensional biotechnology company specializing in product-oriented research, development, manufacturing of vaccines and bio-therapeutics. Bharat Biotech was established in the year 1996 in Hyderabad, India, & has continuously raised the bar in setting new standards for research, development & commercialization of path breaking technologies through innovation and collaborative research.

Bharat Biotech is one of the first bio-pharma facilities in India to be audited and approved by Korean Food & Drugs Administration (KFDA). Bharat Biotech is also a WHO prequalified manufacturer of Hepatitis-B vaccines for supply to UNICEF and global procurement agencies. Bharat Biotech is one of the largest manufacturers of anti-rabies vaccines.

--- End ---

Click to Share

Contact Email:
***@gmail.com Email Verified
Source:Sheela Panicker
Country:India
Industry:Children
Tags:who, gavi, gates, unicef, bharat biotech, india, Rotacvirus, vaccine, government, worldwide, un, agencies
Shortcut:prlog.org/11527347
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share